Friesema, Edith C.H.

Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter

Friesema, E. C. H., Ganguly, S., Abdalla, A., Fox, J. E. M., Halestrap, A. P., & Visser, T. J. (2003) · Journal of Biological Chemistry

Thyroid Disorders and TreatmentsDrug Transport and Resistance Mechanisms

Cited by 725

Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation

Friesema, E. C., Grueters, A., Biebermann, H., Krude, H., von Moers, A., Reeser, M., Barrett, T. G., Mancilla, E. E., Svensson, J., Kester, M. H., et al. (2004) · The Lancet

Thyroid Disorders and TreatmentsGenomics and Rare Diseases

Cited by 709

Plasma Membrane Transport of Thyroid Hormones and Its Role in Thyroid Hormone Metabolism and Bioavailability

Hennemann, G., Docter, R., Friesema, E. C. H., de Jong, M., Krenning, E. P., & Visser, T. J. (2001) · Endocrine Reviews

Thyroid Disorders and TreatmentsDrug Transport and Resistance Mechanisms

Cited by 394

Minireview: Thyroid Hormone Transporters: The Knowns and the Unknowns

Visser, W. E., Friesema, E. C. H., & Visser, T. J. (2011) · Molecular Endocrinology

Thyroid Disorders and TreatmentsDrug Transport and Resistance Mechanisms

Cited by 390

Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10

Friesema, E. C. H., Jansen, J., Jachtenberg, J.-W., Visser, W. E., Kester, M. H. A., & Visser, T. J. (2008) · Molecular Endocrinology

Thyroid Disorders and TreatmentsDrug Transport and Resistance Mechanisms

Cited by 285

The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations

Heuer, H., Maier, M. K., Iden, S., Mittag, J., Friesema, E. C. H., Visser, T. J., & Bauer, K. (2005) · Endocrinology

Thyroid Disorders and TreatmentsDrug Transport and Resistance Mechanisms

Cited by 269

Thyroid hormone transporters in health and disease

Jansen, J., Friesema, E. C. H., Milici, C., & Visser, T. J. (2005) · Thyroid

Thyroid Disorders and TreatmentsDrug Transport and Resistance Mechanisms

Cited by 181

Neuroanatomical Pathways for Thyroid Hormone Feedback in the Human Hypothalamus

Alkemade, A., Friesema, E. C., Unmehopa, U. A., Fabriek, B. O., Kuiper, G. G., Leonard, J. L., Wiersinga, W. M., Swaab, D. F., Visser, T. J., & Fliers, E. (2005) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsHypothalamic control of reproductive hormones

Cited by 146

Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations

Visser, W. E., Jansen, J., Friesema, E. C. H., Kester, M. H. A., Mancilla, E., Lundgren, J., van der Knaap, M. S., Lunsing, R. J., Brouwer, O. F., & Visser, T. J. (2009) · Human Mutation

Thyroid Disorders and TreatmentsGenomics and Rare Diseases

Cited by 75

Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution

Kersseboom, S., Kremers, G.-J., Friesema, E. C. H., Visser, W. E., Klootwijk, W., Peeters, R. P., & Visser, T. J. (2013) · Molecular Endocrinology

Thyroid Disorders and TreatmentsDrug Transport and Resistance Mechanisms

Cited by 45

Relevance of Different Cellular Models in Determining the Effects of Mutations on SLC16A2/MCT8 Thyroid Hormone Transporter Function and Genotype-Phenotype Correlation

Capri, Y., Friesema, E. C. H., Kersseboom, S., Touraine, R., Monnier, A., Eymard-Pierre, E., Des Portes, V., De Michele, G., Brady, A. F., Boespflug-Tanguy, O., et al. (2013) · Human Mutation

Genomics and Rare DiseasesThyroid Disorders and Treatments

Cited by 33

Short-Term, Combined Fasting and Exercise Improves Body Composition in Healthy Males

delli Paoli, G., van de Laarschot, D., Friesema, E. C. H., Verkaik, R., Giacco, A., Senese, R., Arp, P. P., Jhamai, P. M., Pagnotta, S. M., Broer, L., et al. (2020) · International Journal of Sport Nutrition and Exercise Metabolism

Dietary Effects on HealthBody Composition Measurement Techniques

Cited by 8